[46], reported that exogenous application of GSH (50 M) mitigates Pb-induced physiological and metabolic impairments by reducing oxidative stress markers (MDA and H 2 O 2 ) levels and increasing SOD, CAT, POD, APX, and GR activity in Gossypium hirsutum
Several lines of therapeutic modalities are currently available to promote hair re-growth or to prevent hair loss
not FDA-approved as of June 2026
SandMan is an advanced, high-potency sleep support formula designed to promote deep, restorative rest and overnight neurological recovery
Triple receptor agonists have the potential to further bridge the efficacy gap in WL between BS and the currently approved obesity pharmacotherapies, with the added potential for other synergistic metabolic benefits, such as improving glycaemia in people with T2D, and treating or preventing MASLD/MASH